Education
About Us
Working with TipRanks
Follow Us
23andMe Holding (MEHCQ)
OTHER OTC:MEHCQ
MEHCQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.47 - $10.82
Previous CloseN/A
VolumeN/A
Average Volume (3M)567.23K
Market Cap
$151.52M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-2.41
Next Earnings
Aug 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.62
Shares Outstanding20,499,552
10 Day Avg. Volume601,624
30 Day Avg. Volume567,231
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
23andMe Holding News
Ownership Overview
41.38%
Insiders
9.28%
Mutual Funds
0.05% Other Institutional Investors
49.29% Public Companies and Individual Investors
MEHCQ FAQ
What was 23andMe Holding’s price range in the past 12 months?
23andMe Holding lowest stock price was $0.47 and its highest was $10.82 in the past 12 months.
What is 23andMe Holding’s market cap?
23andMe Holding’s market cap is $151.52M.
When is 23andMe Holding’s upcoming earnings report date?
23andMe Holding’s upcoming earnings report date is Aug 06, 2025 which is in 51 days.
How were 23andMe Holding’s earnings last quarter?
23andMe Holding released its earnings results on May 22, 2025. The company reported -$3.621 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.621.
Is 23andMe Holding overvalued?
According to Wall Street analysts 23andMe Holding’s price is currently Overvalued.
Does 23andMe Holding pay dividends?
23andMe Holding does not currently pay dividends.
What is 23andMe Holding’s EPS estimate?
23andMe Holding’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 23andMe Holding have?
23andMe Holding has 20,499,552 shares outstanding.
What happened to 23andMe Holding’s price movement after its last earnings report?
23andMe Holding reported an EPS of -$3.621 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.321%.
Which hedge fund is a major shareholder of 23andMe Holding?
Currently, no hedge funds are holding shares in MEHCQ
23andMe Holding Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
MEHCQ Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 7.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.1%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-33.37%
12-Months-Change
Fundamentals
Return on Equity
-324.06%
Trailing 12-Months
Asset Growth
-59.54%
Trailing 12-Months
Company Description
23andMe Holding
23andMe Holding Co. is a consumer genetics and research company that operates in the healthcare sector. It offers direct-to-consumer genetic testing services, providing customers with insights into their ancestry, genetic health risks, and wellness traits. Through its platforms, the company empowers individuals to access, understand, and benefit from the human genome, thereby promoting personalized healthcare and fostering genetic research.
MEHCQ Revenue Breakdown
100.00% Consumer & Research Services
0.00% Therapeutics
Technical Analysis
Myriad Genetics
―
Fulgent Genetics
―
Burning Rock Biotech
―
Biodesix
―
Prenetics Group
―